Article Details

Dosing Starts in Phase 3 Trial of ALZ-801 in Patients With APOE Variant

Retrieved on: 2021-06-15 16:52:30

Tags for this article:

Click the tags to see associated articles and topics

Dosing Starts in Phase 3 Trial of ALZ-801 in Patients With APOE Variant. View article details on hiswai:

Excerpt

... a treatment with monoclonal antibodies, which remove amyloid plaques from the brain,” Anton Porsteinsson, MD, director of the Alzheimer's Disease ...

Article found on: alzheimersnewstoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up